Zhengming Jin

Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial

Yining Huang, Richard I. Lindley, Xiaoying Chen et al. · The Lancet · 2019 · 271 citations · Full text

Medicine, Cardiology, Pharmacotherapy +13

Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial

Yuankai Shi, Hang Su, Yongping Song et al. · The Lancet Haematology · 2019 · 249 citations

Life Sciences, Immunology, Oncology +7

Radiation Priming Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma With High Tumor Burden

Changju Qu, Nana Ping, Liqing Kang et al. · Journal of Immunotherapy · 2019 · 94 citations

Medicine, Oncology, Radiation Oncology +17

Extramedullary Relapse of Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Different Characteristics between Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia

Ling Ge, Fan Ye, Xinliang Mao et al. · Biology of Blood and Marrow Transplantation · 2014 · 68 citations · Full text

Medicine, Hematology, Oncology +14

Comparison of outcomes in mixed phenotype acute leukemia patients treated with chemotherapy and stem cell transplantation versus chemotherapy alone

Hong Tian, Yang Xu, Liming Liu et al. · Leukemia Research · 2016 · 49 citations

Medicine, Hematology, Oncology +14